Displaying 81 - 100 of 210 results

Priority 3: Using Data Science, Artificial Intelligence and Machine Learning (AI/ML), and Computational Biology to Advance Knowledge and Treatments

https://www.niams.nih.gov/about/strategic-plan-fiscal-years-2025-2029/strategic-goals-priorities/research-priorities/data-science-artificial-intelligence-machine-learning-computational-biology

NIAMS leverages AI/ML and data science to improve treatments, foster collaborations, ensure data stewardship, and advance patient-specific research and tools.

Community Collaboration Advances NIAMS Resource Development

https://www.niams.nih.gov/about/about-the-director/letter/community-collaboration-advances-niams-resource-development

When I joined NIAMS three and a half years ago, I talked about my commitment to collaboration and learning from the NIAMS community in my first director’s letter. Since then, we have done a lot of both collaborating and learning! I highly value the input from the NIAMS community on the development of our resources and in determining the direction of our research so that we are addressing the needs of the various audiences we serve, from researchers and medical providers to patients and caregivers. NIAMS regularly solicits feedback to understand audience needs. Over the past two years, the NIAMS

R03 Information for NIAMS K Award Recipients

https://www.niams.nih.gov/grants-funding/research-training-and-career-development-programs/r03-information-niams-k-award

NIAMS Small Grant Program for New Investigators (R03) Read the NOFO: Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed) Program Purpose: The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is seeking small grant (R03) applications to stimulate

NIAMS Aims to Broaden Support for Our Mission By Expanding Our Funding Approach

https://www.niams.nih.gov/about/about-the-director/letter/niams-aims-broaden-support-our-mission-expanding-our-funding

NIAMS strives to advance the best science on arthritis, musculoskeletal, and skin diseases, which have a profound effect on the quality of life for millions of Americans. To further the NIAMS mission—and importantly, to best steward the resources allocated to us by Congress—we are making some changes to our funding approach and strategy. These include reserving a larger portion of funding to support applications beyond the payline (which is the funding percentile up to which almost all grant applications will be funded). Historically, NIAMS has paid most of its applications according to a strict payline-driven approach, with limited funds available

FY 2019 Funding Plan

https://www.niams.nih.gov/about/budget/fy2019

NIAMS FY 2019 Enacted Level: $605,065,000 The NIAMS is operating under the FY 2019 Department of Defense and Labor, Health and Human Services, and Education Appropriations Act. The interim funding plan below for research and training grants represents the most current information as of the date cited above; however, many

New Pilot Program Will Mentor Leaders and Advance Women’s Health

https://www.niams.nih.gov/about/about-the-director/letter/new-pilot-program-will-mentor-leaders-and-advance-womens-health

We are pleased to announce a new and exciting program designed to create a more robust cadre of researchers dedicated to women’s health research. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the NIH Office of Research on Women’s Health (ORWH) are partnering to launch a pilot program to support and train research scholars by helping them acquire and hone team science leadership and mentoring skills. The Team Science Leadership Scholars Program (LSP) will be funded by ORWH and embedded within the Accelerating Medicines Partnership® Autoimmune and Immune-Mediated Diseases (AMP® AIM) program, which NIAMS and ORWH both support1.

Typically materials from NIAMS that are more than 5 years old will be archived.

Back to Top